PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE!!

In the first interim efficacy study, vaccine candidates were shown to be more than 90 per cent successful in preventing COVID-19 in participants without evidence of previous SARS-CoV-2 infection.In the trial subjects, the study examined 94 reported cases of COVID-1943,538 participants were included in the study, with 42 percent having...